"The U.S. Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths tha"...
Vectibix Patient Information including How Should I Take
In this Article
- What is panitumumab (Vectibix)?
- What are the possible side effects of panitumumab (Vectibix)?
- What is the most important information I should know about panitumumab (Vectibix)?
- What should I discuss with my health care provider before receiving panitumumab (Vectibix)?
- How is panitumumab given (Vectibix)?
- What happens if I miss a dose (Vectibix)?
- What happens if I overdose (Vectibix)?
- What should I avoid while taking panitumumab (Vectibix)?
- What other drugs will affect panitumumab (Vectibix)?
- Where can I get more information?
What should I discuss with my health care provider before receiving panitumumab (Vectibix)?
This medication may cause severe skin problems such as acne, itching, redness, skin rash, dryness, peeling, cracking, or oozing, and swelling or infection around your fingernails or toenails. More severe forms of skin problems can lead to widespread infection and possibly death. Seek emergency medical attention at the first sign of any skin rash.
You should not use panitumumab if you are allergic to it.
Before you receive this medication, you may need to undergo a biopsy to make sure panitumumab is the right medication to treat your cancer.
To make sure panitumumab is safe for you, tell your doctor if you have any of these conditions:
- allergies or breathing problems;
- an ulcer on the cornea of your eye (keratitis); or
- an electrolyte imbalance (such as low levels of calcium or magnesium in your blood).
FDA pregnancy category C. It is not known whether panitumumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
Use birth control to prevent pregnancy while you are receiving panitumumab, whether you are a man or a woman. Panitumumab use by either parent may cause birth defects. Continue using birth control for 6 months after you stop receiving this medication.
It is not known whether panitumumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using panitumumab.
You may have irregular menstrual periods while receiving panitumumab.
How is panitumumab given (Vectibix)?
Panitumumab is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Panitumumab must be given slowly, and the IV infusion can take up to 90 minutes to complete.
Panitumumab is usually given once every 2 weeks. Follow your doctor's instructions.
To be sure this medication is not causing harmful effects, your blood may need to be tested often. Panitumumab can have long lasting effects on your body. Do not miss any follow up visits to your doctor, which may include at least 8 weeks after you stop using panitumumab.
Additional Vectibix Information
Vectibix - User Reviews
Vectibix User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.